DR-TB Drugs Under the Microscope
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
This report presents the results of a survey of 29 countries on national TB policies and practices. The report was created to identify gaps in implementation and monitor progress towards ending TB.
This video discusses the human, scientific, and historic impact of TB. The video also includes interviews with TB patients and health care workers.
This fact sheet provides an overview of TB diagnosis, treatment, and drug-resistant TB. It also reviews the Medecins Sans Frontieres (MSF), campaign for Access to Essential Medicines, which has dealt with TB since its first day of operations more than 30 years ago.
This is the story of one patient's experience with TB disease and HIV.
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
This infographic discusses the global impact of multidrug-resistant TB (MDR TB). Two patient stories are also included in the infographic.
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.